Lv1
30 积分 2025-09-03 加入
Inflame and restrain — the paradoxical roles of IL-12 and IL-23 in immunity
22天前
已完结
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
23天前
已完结
POS0803 VUNAKIZUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A RANDOMIZED, DOUBLE-BLIND, ADAPTIVE, SEAMLESS, PHASE 2/3 STUDY
23天前
已完结
Development of Romiplostim: A Novel Engineered Peptibody
1个月前
已完结
Efficient refolding of recombinant reteplase expressed in Escherichia coli strains using response surface methodology
1个月前
已完结
Comparability of biosimilar romiplostim with originator: Protein characterization, animal pharmacodynamics and pharmacokinetics
1个月前
已完结
A Review on Romiplostim Mechanism of Action and the ExpressiveApproach in E. coli
1个月前
已完结
Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants
2个月前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
2个月前
已完结
Why obesity is a disease - Pathogenesis and diagnosis
3个月前
已完结
皖公网安备34019202002308
